Sirolimus
Sirolimus
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]-oxaazacyclohentriacontin-1,5,11,28,29(4H,6H,31H)penton
Stoffgruppe
Antineoplastisches Mittel, Immunsuppressivum (mTOR-Kinase-Inhibitor)
Halbwertszeit
62 ± 16 h
Hämodialyse
nein
Präparate
Hyftor 2 mg/g Gel
Sirolimus
Rapamune® 1 mg/ml Lösung zum Einnehmen
Sirolimus